(Q44255938)

1 December 2017

title

Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation (English)

1 reference

1 December 2017

M Peyre

1

1 reference

1 December 2017

A Stemmer-Rachamimov

2

1 reference

1 December 2017

E Clermont-Taranchon

3

1 reference

1 December 2017

S Quentin

4

1 reference

1 December 2017

N El-Taraya

5

1 reference

1 December 2017

C Walczak

6

1 reference

1 December 2017

A Volk

7

1 reference

1 December 2017

M Niwa-Kawakita

8

1 reference

1 December 2017

N Karboul

9

1 reference

1 December 2017

M Giovannini

10

1 reference

1 December 2017

M Kalamarides

11

1 reference

1 December 2017

language of work or name

English

0 references

publication date

8 October 2012

1 reference

1 December 2017

1 reference

1 December 2017

volume

32

1 reference

1 December 2017

issue

36

1 reference

1 December 2017

page(s)

4264-4272

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2012.436

1 December 2017

exact match

0 references

cites work

Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

A review of malignant meningiomas: diagnosis, characteristics, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

Histological classification and molecular genetics of meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

Genomic Profiling Reveals Alternative Genetic Pathways of Meningioma Malignant Progression Dependent on the UnderlyingNF2Status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

The regulation of INK4/ARF in cancer and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

A comparison of the cell lines used in meningioma research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

N-ethyl-N-nitrosourea (ENU)-induced meningiomatosis and meningioma in p16(INK4a)/p19(ARF) tumor suppressor gene-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

Senescence in tumours: evidence from mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

A conditional mouse model for malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

2D and 3D radial multi-gradient-echo DCE MRI in murine tumor models with dynamic R*2-corrected R1 mapping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

Very CIN-ful: whole chromosome instability promotes tumor suppressor loss of heterozygosity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

Tumour biology: senescence in premalignant tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

Comparisons of the efficacy of a Jak1/2 inhibitor (AZD1480) with a VEGF signaling inhibitor (cediranib) and sham treatments in mouse tumors using DCE-MRI, DW-MRI, and histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: an exploratory study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

Allelic losses in neurofibromatosis 2-associated meningiomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

Association of loss of 1p and alterations of chromosome 14 in meningioma progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative 'tumor progression' locus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

Immunohistochemical analysis of p16INK4a, p14ARF, p18INK4c, p21CIP1, p27KIP1 and p73 expression in 271 meningiomas correlation with tumor grade and clinical outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

Bevacizumab-induced regression of anaplastic meningioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

Radiographic regression of cranial meningioma in a NF2 patient treated by bevacizumab

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

Allelic gain and amplification on the long arm of chromosome 17 in anaplastic meningiomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.436

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/ONC.2012.436

1 reference

1 December 2017

1 reference